抗血小板疗法是缺血性脑血管病治疗中的主要策略，研究证据最多。
Antiplatelet therapy is a major strategy with a growing body of evidence in management of ischemic cerebrovascular diseases.
由于阿司匹林单一疗法可导致症状加重，需要使用双重抗血小板疗法。
Extended medication with dual antiplatelet therapy was required because dose reduction to aspirin monotherapy worsened symptoms.
尽管普遍认为抗凝疗法可预防静脉血栓形成，双重抗血小板疗法仍可用来治疗适应性较差的患者。
Although it is presumed that prevention of venous thrombosis is best achieved with anticoagulation, dual antiplatelet therapy can be a substitute for patients with poor compliance.
应用推荐